This study provides the first evidence of the clinical significance of PRR13 in breast cancer, suggesting that PRR13 may be involved in the initiation and progression of breast cancer and may therefore be useful in stratifying patients with more aggressive behaviour and may serve as an important prognostic index and potential therapeutic target. This evidence concerns the gene PRR13 and breast carcinoma.